ROSSITTO, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 2470
EU - Europa 274
AS - Asia 126
OC - Oceania 2
Totale 2872
Nazione #
US - Stati Uniti d'America 2467
CN - Cina 97
IT - Italia 95
SE - Svezia 79
FI - Finlandia 41
GB - Regno Unito 29
VN - Vietnam 19
DE - Germania 14
IN - India 10
NL - Olanda 7
UA - Ucraina 6
AU - Australia 2
CA - Canada 2
CH - Svizzera 1
DK - Danimarca 1
MX - Messico 1
PL - Polonia 1
Totale 2872
Città #
Fairfield 575
Woodbridge 288
Ann Arbor 248
Houston 236
Ashburn 209
Seattle 181
Cambridge 172
Wilmington 150
Chandler 91
San Diego 60
Medford 49
Princeton 49
Padova 48
Roxbury 35
Des Moines 32
Nanjing 26
Beijing 23
Helsinki 23
Dong Ket 19
Jacksonville 12
Jinan 9
Hebei 6
Norwalk 6
Las Vegas 4
Redwood City 4
Shenyang 4
Phoenix 3
Pontecchio Polesine 3
Zhengzhou 3
Amsterdam 2
Baotou 2
Borås 2
Changsha 2
Hangzhou 2
Jiaxing 2
Ningbo 2
Orange 2
Redmond 2
Rome 2
Villorba 2
Brierley Hill 1
Buffalo 1
Chongqing 1
Fuzhou 1
Guangzhou 1
Haikou 1
Huizen 1
Indiana 1
Kherson 1
Kongens Lyngby 1
Lanzhou 1
Lishui 1
Milan 1
Nanchang 1
Quzhou 1
Reggio Nell'emilia 1
Rockville 1
Springs 1
Taizhou 1
Tianjin 1
Verona 1
Vittuone 1
Totale 2612
Nome #
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 155
Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension 133
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. 129
The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua) 125
Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease. 113
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 111
Oral burning with dysphagia and weight loss 95
Systolic and diastolic short-term blood pressure variability and its determinants in patients with controlled and uncontrolled hypertension: A retrospective cohort study 93
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 93
Adrenal venous sampling in dye-allergic primary aldosteronism patients: prevalence, pitfalls and a possible solution 89
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. 87
AT1AA (Angiotensin II Type-1 Receptor Autoantibodies): Cause or Consequence of Human Primary Aldosteronism? 87
Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. 86
Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders 85
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design 85
Elevation of Angiotensin-II Type-1-Receptor Autoantibodies Titer in Primary Aldosteronism as a Result of Aldosterone-Producing Adenoma. 83
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. 80
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 75
A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma 75
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 73
Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis. 63
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 61
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization 56
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 55
Cell-mediated autoimmune mechanisms involved in the pathogenesis of primary aldosteronism. 53
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 52
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 51
Tissue sodium excess is not hypertonic and reflects extracellular volume expansion 51
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 48
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 44
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 40
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 29
Haemodynamic assessment in hypertension: the soloists and the orchestra 28
Management of hypertensive emergencies: a practical approach 28
Clinical Outcomes of 1625 Patients with Primary Aldosteronism Subtyped with Adrenal Vein Sampling 28
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study 27
Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction 26
Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large Multiethnic International Study 25
Adrenal venous sampling but not computed tomography is essential before undertaking adrenalectomy for primary aldosteronism 25
Dr Giacomo Rossitto interviews Professor Rhian Touyz, on the translational applications of vascular smooth muscle cell biology in cardiovascular disease 24
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 24
Q: Should alpha-blockers ever be used as antihypertensive drugs? 21
Feasibility of imaging-guided adrenalectomy in young patients with primary aldosteronism 21
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 20
Antibodies to malondialdehyde oxidized LDL predict cardiovascular events during long-term follow-up in high risk coronary artery disease patients. 19
Response to the letter regarding the hypothesis paper “Much ado about N . . . Atrium: Modelling tissue sodium as a highly sensitive marker of subclinical and localised oedema” 19
Much Ado about N⋯ atrium: Modelling tissue sodium as a highly sensitive marker of subclinical and localized oedema 17
Modern Management of Hypertensive Emergencies 10
Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study 9
Management and Outcomes of Primary Aldosteronism in Pregnancy: A Systematic Review 8
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 6
Letter to the Editor From Paolo Rossi and Rossitto: "Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism" 2
Ipertensione e surrene 1
Does Excess Tissue Sodium Storage Regulate Blood Pressure? 1
Salt loading decreases urinary excretion and increases intracellular accumulation of uromodulin in stroke-prone spontaneously hypertensive rats 1
Of Snails, Earthworms, and Men: Insights into Strategies to Preserve Water 1
Pathophysiology of Hypertension 1
Antihypertensive Drugs and Vascular Health 1
The Lymphatic System 1
Totale 2949
Categoria #
all - tutte 4277
article - articoli 4203
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 74
Totale 8554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201883 00119 31 119 212232
2018/2019239 1057 21 016 3299283
2019/2020556 7133428 5833 7060 83414035
2020/2021933 26433931 2211 14150 7224544209
2021/2022707 24453862 6293 3752 485434158
2022/2023180 11446200 00 00 0000
Totale 2949